α-Bulnesene, a novel PAF receptor antagonist isolated from Pogostemon cablin

Hui Chun Hsu, Wen Chia Yang, Wei Jern Tsai, Chien Chih Chen, Hui Yu Huang, Ying Chieh Tsai

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

α-Bulnesene is a sesquiterpenoid isolated from the water extract of Pogostemon cablin. It showed a potent and concentration-dependent inhibitory effect on platelet-activating factor (PAF) and arachidonic acid (AA) induced rabbit platelet aggregation. In a radioligand binding assay for the PAF receptor, α-bulnesene competitively inhibited [3H]PAF binding to the PAF receptor with an IC50 value of 17.62 ± 5.68 μM. α-Bulnesene also dose-dependently inhibited PAF-induced intracellular Ca2+ increase in fluo-3/AM-loaded platelets (IC50 values of 19.62 ± 1.32 μM). Furthermore, α-bulnesene inhibited AA-induced thromboxane B2 (TXB2) formation and prostaglandin E2 (PGE2) formation. These results indicate that the inhibitory effect of α-bulnesene on platelet aggregation was due to a dual activity; specifically the chemical blocked PAF-induced intracellular signal transduction and interfered with cyclooxygenase activity, which resulted in a decrease in thromboxane formation. This study is the first to demonstrate that α-bulnesene is a PAF receptor antagonist as well as an anti-platelet aggregation agent.

Original languageEnglish
Pages (from-to)1033-1038
Number of pages6
JournalBiochemical and Biophysical Research Communications
Volume345
Issue number3
DOIs
Publication statusPublished - Jul 7 2006
Externally publishedYes

Fingerprint

Platelet Activating Factor
Platelets
Platelet Aggregation
Agglomeration
Arachidonic Acid
Inhibitory Concentration 50
Signal transduction
Thromboxane B2
Radioligand Assay
Thromboxanes
Prostaglandin-Endoperoxide Synthases
Dinoprostone
Assays
Signal Transduction
Blood Platelets
Rabbits
Pogostemon
platelet activating factor receptor
Water

Keywords

  • α-Bulnesene
  • Arachidonic acid (AA)
  • Platelet aggregation
  • Platelet-activating factor (PAF)
  • Pogostemon cablin
  • Sesquiterpenoid

ASJC Scopus subject areas

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

α-Bulnesene, a novel PAF receptor antagonist isolated from Pogostemon cablin. / Hsu, Hui Chun; Yang, Wen Chia; Tsai, Wei Jern; Chen, Chien Chih; Huang, Hui Yu; Tsai, Ying Chieh.

In: Biochemical and Biophysical Research Communications, Vol. 345, No. 3, 07.07.2006, p. 1033-1038.

Research output: Contribution to journalArticle

Hsu, Hui Chun ; Yang, Wen Chia ; Tsai, Wei Jern ; Chen, Chien Chih ; Huang, Hui Yu ; Tsai, Ying Chieh. / α-Bulnesene, a novel PAF receptor antagonist isolated from Pogostemon cablin. In: Biochemical and Biophysical Research Communications. 2006 ; Vol. 345, No. 3. pp. 1033-1038.
@article{464b85fa3fd442ec95cb05d04579e006,
title = "α-Bulnesene, a novel PAF receptor antagonist isolated from Pogostemon cablin",
abstract = "α-Bulnesene is a sesquiterpenoid isolated from the water extract of Pogostemon cablin. It showed a potent and concentration-dependent inhibitory effect on platelet-activating factor (PAF) and arachidonic acid (AA) induced rabbit platelet aggregation. In a radioligand binding assay for the PAF receptor, α-bulnesene competitively inhibited [3H]PAF binding to the PAF receptor with an IC50 value of 17.62 ± 5.68 μM. α-Bulnesene also dose-dependently inhibited PAF-induced intracellular Ca2+ increase in fluo-3/AM-loaded platelets (IC50 values of 19.62 ± 1.32 μM). Furthermore, α-bulnesene inhibited AA-induced thromboxane B2 (TXB2) formation and prostaglandin E2 (PGE2) formation. These results indicate that the inhibitory effect of α-bulnesene on platelet aggregation was due to a dual activity; specifically the chemical blocked PAF-induced intracellular signal transduction and interfered with cyclooxygenase activity, which resulted in a decrease in thromboxane formation. This study is the first to demonstrate that α-bulnesene is a PAF receptor antagonist as well as an anti-platelet aggregation agent.",
keywords = "α-Bulnesene, Arachidonic acid (AA), Platelet aggregation, Platelet-activating factor (PAF), Pogostemon cablin, Sesquiterpenoid",
author = "Hsu, {Hui Chun} and Yang, {Wen Chia} and Tsai, {Wei Jern} and Chen, {Chien Chih} and Huang, {Hui Yu} and Tsai, {Ying Chieh}",
year = "2006",
month = "7",
day = "7",
doi = "10.1016/j.bbrc.2006.05.006",
language = "English",
volume = "345",
pages = "1033--1038",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Elsevier B.V.",
number = "3",

}

TY - JOUR

T1 - α-Bulnesene, a novel PAF receptor antagonist isolated from Pogostemon cablin

AU - Hsu, Hui Chun

AU - Yang, Wen Chia

AU - Tsai, Wei Jern

AU - Chen, Chien Chih

AU - Huang, Hui Yu

AU - Tsai, Ying Chieh

PY - 2006/7/7

Y1 - 2006/7/7

N2 - α-Bulnesene is a sesquiterpenoid isolated from the water extract of Pogostemon cablin. It showed a potent and concentration-dependent inhibitory effect on platelet-activating factor (PAF) and arachidonic acid (AA) induced rabbit platelet aggregation. In a radioligand binding assay for the PAF receptor, α-bulnesene competitively inhibited [3H]PAF binding to the PAF receptor with an IC50 value of 17.62 ± 5.68 μM. α-Bulnesene also dose-dependently inhibited PAF-induced intracellular Ca2+ increase in fluo-3/AM-loaded platelets (IC50 values of 19.62 ± 1.32 μM). Furthermore, α-bulnesene inhibited AA-induced thromboxane B2 (TXB2) formation and prostaglandin E2 (PGE2) formation. These results indicate that the inhibitory effect of α-bulnesene on platelet aggregation was due to a dual activity; specifically the chemical blocked PAF-induced intracellular signal transduction and interfered with cyclooxygenase activity, which resulted in a decrease in thromboxane formation. This study is the first to demonstrate that α-bulnesene is a PAF receptor antagonist as well as an anti-platelet aggregation agent.

AB - α-Bulnesene is a sesquiterpenoid isolated from the water extract of Pogostemon cablin. It showed a potent and concentration-dependent inhibitory effect on platelet-activating factor (PAF) and arachidonic acid (AA) induced rabbit platelet aggregation. In a radioligand binding assay for the PAF receptor, α-bulnesene competitively inhibited [3H]PAF binding to the PAF receptor with an IC50 value of 17.62 ± 5.68 μM. α-Bulnesene also dose-dependently inhibited PAF-induced intracellular Ca2+ increase in fluo-3/AM-loaded platelets (IC50 values of 19.62 ± 1.32 μM). Furthermore, α-bulnesene inhibited AA-induced thromboxane B2 (TXB2) formation and prostaglandin E2 (PGE2) formation. These results indicate that the inhibitory effect of α-bulnesene on platelet aggregation was due to a dual activity; specifically the chemical blocked PAF-induced intracellular signal transduction and interfered with cyclooxygenase activity, which resulted in a decrease in thromboxane formation. This study is the first to demonstrate that α-bulnesene is a PAF receptor antagonist as well as an anti-platelet aggregation agent.

KW - α-Bulnesene

KW - Arachidonic acid (AA)

KW - Platelet aggregation

KW - Platelet-activating factor (PAF)

KW - Pogostemon cablin

KW - Sesquiterpenoid

UR - http://www.scopus.com/inward/record.url?scp=33646837647&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646837647&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2006.05.006

DO - 10.1016/j.bbrc.2006.05.006

M3 - Article

C2 - 16712790

AN - SCOPUS:33646837647

VL - 345

SP - 1033

EP - 1038

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 3

ER -